150
Adiprayitno Med J IndonesInfluence of
protein
kinase
C
inhibitor
in phagocytosis
activity toward
Candida
sp
Adiprayitno
Abstrak
Protein kinase C, yang dapat diekspresikan oleh hampir semua sel adalah protein yang penting dalam alur sinyal transduksi yang berperan dnlam sejumlah aktivitas sel, seperti berbagai macam hormon, sitokin, neurotransmiter dan growth
faktor.
Imunitas terhadap Candida sp antarolain
ditentukan oleh sel limfosit T dan makrofag. Sebagai obyek penelitianini
adalah bagaimana pengaruh inhibitor protein kinase C-
bisindolylmaleimides pada aktivitas fagisitosis Candida sp oleh makrofag. Kultur makrofag peritoneal mencit BALB/c diberi perlakuan dengan memberikan bisindolylmaleimides dari kadar 5 ng/ml sampai 100 ng/ml seLama I0 menit. Kemudian segera dimasukkan Candida sp dnn diamati setiap30
menit selamn 120 menit. Rancangan penelitian yang digunakan adalah rancanganfaktorial
dan ortogonal polinomial. Data yang dikumpulkan berupa panjang pseudopodia dan banyaknya Candida sp yang difagositosis serta lamanya waktu pengamatan dianalisis denganuji
statistik Anova (satu jalan) untuk memperlihatkan perbedaan diantara perlakuan-perlakuan, Anova duajalan
untuk memperlihatkan interaksi antara perlakuan-perlakuan dan Student'st
Test untuk memperlihatkan perbedaan terhadap kontrol. Test statistik memperlihatkan perbedaan yang bermakna pada panjangnya pseudopodia dan banyaknya Candida sp y(tng dfcgositosis pada pemberian berbagai macam kadar bisindolylmaleimides (p<0,001) dan lamanya waktu pengamatan (p<0,001)., Interaksi antara pemberianbe
kadar bisindolylmaleimides dengan Inmanya waktu pengamatan sangat bermakna (p<0,001). Semakin tinggikadar
imides yang diberikan, semakin awal waktu pengamatan,makn
semakin banyak protein kinase C yang tidak aktif dan semakin pendek panjang pseudopodia atau semakin menurun aktivitas fagositosis Candida sp oleh makrofag.Ilasil
penelitittn menunjukkan bahwa bisindolylmaleimides dapat menghambat mobilitas dan aktivitas fagositosis Candida sp oleh makrofag. Penelitian lebih jauh tentang protein kinase C, terutama pada makrofag, sangat dianjurkan. (Med J Indones 2001; 10: 150-7)Abstract
Protein kinase C isoenzyme family that expresses in all of cells plays a pivotal role in the signal transduction pathway of a variety
of
hormones, cytokines, neurotransmitter, and growth factors. The immunity against Candida sp is mainly mediated and petformed bythe
T cells
and
macrophages. The objectiveof
this
experimentis
to
knowthe
influence theprotein
kinase Cinhibitor
-bisindolytmaleimides in phagocytosis activity toward Candida sp. The culture of peritoneal macrophage derived front BALB/c mice are treated with bisindolyLnnleimides as a protein kinase C inhibitor concentration varied from 5 ng/ml to 100 ng/mlfor
as long asl0
minute. Then the Candida sp added is observed after every 30 minutefor
as long as 120 minute. As the experimental design is used the method offactorial and orthogonal polynomial. The data consisting the length of psewdopodia and the number of Candida sp which are phagocytosed are analyzed applying the Anova. One Way Anova to show the differences of each manipulation, the Two Way Anova to show the interaction of manipulations and the Student'st
Test to show the differences with control. Statistical test show significant dffirences on the length of pseudopodia, and phagocytosed Candida sp, dt different bisindolylmaleimides concentration (p<0,001) anddffirent
observed time (p<0,001). The data show asignifcant
interaction betvveenthe
bisindolylmaleimides concentration and observed time (p<0,001). The higher the bisindob,lmaleimides concentration, the earlier the observed time, the much number the protein kinase C are going inactive and the sh.orter the length of pseudopodiaor
the Lower the macrophages phagocytic activity toward Candida sp. The result of this experiment indicates that bisindolylmaleimides can inhibit the macrophage mobility and phagocytic activity toward Candida sp. Further experiment in protein kinase C, especially in macrophage, is suggesied. (MedI
Indones 2001;I0:
150-7)Keywords: Signal Transduction, protein Kiruse C, bisinàolylmaleimides, phagocytosis
Vol 10, No 3, July
-
September 2001Signal
transduction
It
is essentialfbr their
survival
thatcells
communicatewith their
neighbors,
monitor the
conditions
in
their
environment, and respond appropriately
to
a
host
of
ditferent type
of
stimuh that impinge
ontheir
surface.Cells carry out
these interaction
by
the
phenomenonknown as cell signalling,
in
which
information
isrelayed across
the
plasma membrane
to
the
cell
interior
andotien
to thecell
nucleus.rIn
most systems,cell signalling
includes:l.
Recognition
of
thestimulus
at the outer surfaceof
the
plasma membrane
by
a
specific
receptor embeddedwithin
the membrane.2.
Transfèr
of
asignal
acrossthe
plasma membrane toits cytoplasm
surface.3.
Transmission of
the
signal
to specifïc
receptormolecules
on the inner
surface
of
the
membraneor
within
the
cytoplasm
that
trigger
the
cell's response.The
responsemight
involve
a changein
gene expression,
an alteration
of
the activity of
metabolic
enzymes, areconfiguration
of
the
cyto-skeleton, a change in ion permeability, the activation theDNA
synthesis. or even the death of the cell.4.
Cessation
of the
response
as
a
result
of
thedestruction or inactivation
of
the signaling moleculecombined
with
a
decrease
in
the
level of
theextracellular
stimulus. IFrotein
kinase C
Protein kinase
C
(PKC)
family
is a
heterogeneousfamrly of
phospholipid-dependent
kinasesthat
can bedivided into
three categorieson
the basisof
co-factor
requirement
and
structure.t'3
Prolein
kinase
C
as
anisoenzyme
plays
a very pivotai role
to
generate thesignal
in
the
transductron pathway.
Protein
kinase
Chas
a number
of
important roles
in
cellular
growth.
differentiati on, metabol i sm, an d transcriptional activation,most
of
which
arenot well
understood.la ConventionalPKC
requires
calcium and diacylglycerol (DAG)
orphorbol
ester ascofactor
whereasnovel PKC
requiresonly
DAG or
phorbol
ester.
Atypical PKC
do
not
require calcium
orDAG for
maximal
activity.
Protein
kinase
C
consist of
a
single polypeptide chain
thatcontains
an
amino-terminal regulatory
region
(20-70
kD)
and a carboxy-terminal kinase domain
(approxi-mately
45
kD).
The
catalytic domain contains
theATP-binding and
substrate-binding.
This domain
isInfluence of protein kinase C
inhibitor
1 5l
separate from regulatory
domain
containing
PS-binding
andphorbol ester-binding
site.2Bisindolylmaleimides
is a potent and selectiveinhibitor
of
Protein kinase
C
provides evident
for
thepotential
useof
PKC inhibitor
as therapeutic immunomodulators.This compound
alsoselectively inhibited
the secondaryT
cell
mediated responsein the
developing
adjuvantarthritis model
in
rats.3Bisindolylmaleimides was
acompetitive
inhibitor with
respect toATP
and displayedhigh selectivity
for PKC.3'4
Many inhibitors
in
two
different domains have already been described: calphostinC
and
sphingosinewhich
interact
with the
regulatory
moiety and
sangivamycin,
the isoquinoline
H7
and staurosporine which interactwith
theATP-binding
site.aImmunity
to
fungi
T
cell
and
macrophage
are very importance
in
theimmunity
to
fungi. T cell immunity is
also implicated
in
resistanceto
otherfungal
infection,
since resistance can sometimes be transferredwith
immune
T
cell.
It
ispresumed
that
Th
cells
release
cytokines
which
activate macrophagesto destroy
the fungi.5-eLittle
areknown about
the
precise
mechanisms
involved
in
immunity
to
fungal infection, but
it
is
thought
thatthey
are
essentially
similar
to
those
involved
in
resistance tobacterial infections.
Macrophage
The classic studies have
clearly
shown that monocytestransform
into
macrophagesand multinucleated giant
cells
in
vitro.
Incorporation
of
the
surroundingmedium
andsoluble molecules
by
invagination
of
thecell
surface,
pinocytosis
and
macropinocytosis,
becameincreasingly
active
asthe monocyte
changesinto
the macrophage and appearto
increasein activity
with
associated
increase
in
metabolic
activity.
Phagocytosis
can
be
divided
into several
phaseswhich
areattachment, ingestion,
secondary lysosomeformation
(enzymatic degraded),
and'vesicle
closureand
disposal
of
degradated
material.r0
As
the organismmove,
portion of
thecell
surface are seen tobe
pushed
outward by the column
of
the
cytoplasm
that
flows
through the
interior
of
the
cell toward
theperiphery.
The
broad, rounded protrusions
formed
during ameboid movement are called
pseudopodia.Ingestion then occurs
asthe phagocyte
surrounds the152
AdiprayitnoCandida
spCandida
are agroup
of fungi
which
producelocalized
diseaseof
skin
and mucous membrane.
In
immuno-compromised
hosts they can
cause
invasive
and/ordisseminated disease.
They are
emerging
as
animportant nosocomially acquired pathogen
and
afrequent opportunistic
infection
in
the
setting of
neutropenia and
AIDS. Most
infection
is
acquiredendogenously,
typically
from the
gastrointestinaltract,
with
diseaseproduced
either by
breakdown
of
normal barriers
or by
overgrowth
of
normal
flora.
Other
pathogenic
factors include
extra
cellular
enzymes (such as phospholipase and
proteases) andcell wall
mannans,
which produce
anaphylaxis
anddeath
in animal model.rr'
r2METHODS
Cells
Peritoneal-derived
macrophageswere
obtainedby the
method
of
Collisan et. al.
with some modifications.
(r3)
we
have fiie male mice
BALB/c
from
Hayati
Laboratory, Gajah Mada
University.
1.5
ml
syringe
was
filled
with
1.0
ml
of
Freund's
Adjuvants
Incomplete (Sigma Chem.
Co.
St.Louis, USA)
and a25-G
needle
was attached,
the
solution was
theninjected
into the
peritoneal
cavity
of
each mouse.
Inflammatory
response wasalloned
for
7 days and themice
were
killed by cervical
dislocation.
The
mouseabdomens
were
washed
with 70Vc alcohol
to
sterilethe
area.
Midline
incision
was
made
with
sterilescissors.
The
abdominal
skin
'was retracted
with
forceps
to
exposethe intact peritoneal
wall.
A
10ml
syringe
was attachedwith
19-G needle and thenfilled
with the RPMI-1640 medium
(Sigma Chem.
Co. St.
Louis,
USA). The
syringe plunger was
pushed
toallow
a small amôunt
of
medium
to
passthrough
theneedle as
the
needle
penetrates
the
peritoneum
toavoid
hitting the
intestine.
With
bevelled
end
of
needle
facing
up, insert needlethrough peritoneal
wall
at
the
midline.
Inject
1O-mlRPMI-I640
medium into
each mouse.
Using
the samesyringe
and needle,insert
needle
bevelled end down
into
peritoneum.
Raiseneedle
slightly
to
cause
tenting
of
peritoneal
wall.
Withdraw
peritoneal
fluid
slowly.
remove
needlefrom
syringe and
dispensepooled peritoneal
fluid
to 50ml
polypropylene centrifuge
tubeon ice. 2X10000
peritoneal cells
in
20
rnl
RPMI-1640 medium
wereplated
into
20mm
diameterwells
of a24 well
culture
disk
(Costar).
Before
plated,
place 20-mm
diameterMed J Indones
coverslip
into
the
well. For
most
experiments
cellswere plated
at
1000cells per
well. After allowing
30 minutes atroom
temperaturefor
the suspendedcell
to adhereto the dish, RPMI-1640 medium
was
replacewith
FetalBovine
Serum(GIBCO)
andstreptomycine
7Vo
and fungizone
lVo,
and
the
culture were left
ovemight
atroom
temperaturein incubator.
Influence
of
inhibitor
protein
kinase C
Before
treatment,
the culture medium
were
removedand
the
macrophage
were
washed
extensively
usingPBS-IOF
(PD
:
137 nM-NaCl,
3
nM-KCl,
7
nM-Phosphat
Buffer,
pH
7.4) and
incubated
with
bisindolylmaleimides (Sigma Chem. Co., St.
Louis,
USA)
the protein kinase
C inhibitor
for
l0
minute
atroom
temperature.
The
culture
macrophages
wereadded
to
the
Candida
sp
and observed every
30 minutesfor 120
minutes.laMicroscopy
For
time-lapse, coverslips were
put
and stained with
Giemsa(MERCK). Nikkon
phasemicroscope
imageswere collected
via
a
100
x
objective lens every
30 minutesfor 120
minutes.l5Experimental
design
This
experiment was done in
the laboratory.
As
rn-ependent
variable
the
concentration
of
bisindolyl-aleimides were
used.As
dependentvariables
:
(l)
thelength
of
the pseudopodia;(2)
thenumber
oT Candidasp that
phagocytosedby
macrophage
'uvere used, andas controlled variable
the
observed
time
(every
30minutes)
is
used.
The data consisting the length of
pseudoodia and
the
number
of
Candida sp which
isphagocytosed
are
analyzed
by
applying the
Anova.
One
Way
Anova
to
show
the
diffèrences
of
eachmanipulation,
the Two Way
Anova
to show
theinteraction of manipulations
and the Student'st
Test to show the diffèrenceswith
control.r6RESULT
Pseudopodia
'Figure
l' A
Tlte length of pseudopodia (the arrow) before [reatment witl.r bisindolylmaleimides after 30minutes of observation (200X) B' The length of pseudopodia (the arrow) before treatment with bisindolylnnleimi'des after 30 n i,tut"s oj obrn*otk
,
( I000X).
S'9'
154
AdiprayitnoTable 1, Mean and standard deviation of the
podia
(micrometer)in
various bi sindolylmaleimi des.Med J Indones
length of
pseudo-concentration of the length of pseudopodia ( micrometer ).
Concentration of
bisindolyl-maleimedes
(ng/ml)
X
(after
observed
30 minutes)
70 60 50 40 30 20 10
0 0
5
25
50
100
SD X-SD
X(after
observed 120 minutes)
5-5,9
54,8*
40,2
4,5
l0,l
45,8-66Note
: *
: NS (notsigniftcant). _1glml : nanogram per mililiter.X
:meanSD
: standard deviationthe length of pseudopodia ( micrometer ).
0ng 5ng 25ng
50ng
100n9 [image:5.612.323.544.91.210.2] [image:5.612.47.288.128.429.2]concentration of bisindolylmaleimides ( ng/ml ).
Figure 3. The length of pseudopodia in various concentration
of
bisindolylmaleimides, The higher the bisindolylmaleimides concentration, the shorter the length ofpseudopodia.120'
the time observed (minute).
Figure
4.
The length of pseudopodiain
time observed. Theearlier the obseryed time, the shorter the length of pseudopodia.
Statistical
test
showed
significant
differences
on
thelength of pseudopodia, at
different
bisindolylmaleimidesconcentration
(p<0.001)
and
different
observed time
(p<0.001).
The
data
show
a
signifrcant
interaction
between
the bisindolylmaleimides
concentration
andobserved
time (p<0.00t;.
fne
higher the
bisindolyl-maleimides concentration,
the earlier
observed
time, the morenumber of protein
kinaseC
becameinactive,
the
shorter
the length
of
pseudopodia.
From
T
test were shown asignificant difference
for
concentrations25
nglml
(p=0.00+),
50
ng/ml and
100 ng/ml
(p=0.0001),
no
significant difference were found
atconcentration
5ng/ml.
Phagocytosis
of
Candida
spThe
photographs
and data
of
the experiment
about phagocytosisof
Candidasp were
shownbelow:
70
55*
3l 12
B
A
Figure 5. The number of Candida sp. phagocytosed (the arcow) before the bisindolylmaleimides treatment. A. After 30 minutes of observation ( I 000X). B. After I 20 minutes of ob seruatton.
[image:5.612.231.514.507.701.2]A.
Figure 6. Tlrc nuntber of Candida sp. plngocytosed (llrc arro--) after lreatnenr witlt bisitdolt'lnnleirnides. A. Treattnent
a.ftc130 mirurtes of obr'e rvatiott ( 1000X).
Table
2. Mean and
standard deviationof
the
number of Ccudirla s7r (cell) that were phagocytosedin
various concentrations of bi sindolylmaleirnides.tbe number oT Canilida sp that were phagocytosed.
x
Conccnfration
of
Xbisindolyl-
(after observed rnaleinrdes(ng/rnl)
30 nrinutes)sD
T-sp
Ï
(after obsewed
I 20 rninutes)
90' 60 30'
0 -5 25
.50 l(x)
5,3
4* 2,6*
1,9
0,4
3.3 t-7 I
9,6
6*
4x
1,3
Note: *
:NS(notsignittcant)1g/ml
: nânogram per mililiter.X
: meanSD
: standard deviationthe number of Candida sp that were phagocytosed.
[image:6.612.48.517.87.286.2] [image:6.612.320.500.377.485.2]concentration of bisindolylmaleimides ( ng/ml ).
Figure 7. The number
of
Candida sp phagocytosedin
various concentratiottof
bisindolylmaleimides. The higher theconcen-tration, the lower the number of Candida sp phagocytozised.
the length of observation time (minute).
Ganrbar 8. The number
of
Candida sp phagocytosedin
time observed.. The earlier the observation, the lower the numberof
Candida sp phagocytosed.Statistical
test
showed
significant
differences
onphagocytosed
Candida
sp,
at
different
bisindolyl-maleimides concentration (p<0.001)
and different
observation
time
(p<0.001). The data show a significantinteraction
between thebisindolylmaleimides
concen-tration
and observationtime (p<0.001). The
higher thebisindolylmaleimides concentration,
the
earlier
theobservation
time, the
more number
of
the
protein
kinase
C
are
going
inactive,
and
the lower
themacrophages phagocytosis
activity toward
Candida
sp.
From
T
test
were
shown
a significant
difference
for
concentrations
25 ng/ml
(p=Q.Q04),50 ng/ml
and lQOng/ml
(p=0.0001),
no significant
difference
were [image:6.612.29.271.387.662.2]156
AtliprayitttoDISCLTSSION
Cells
Protease
peptone
-
treated mice
should
yield 3-4
X
1.000.000
macrophagesper
mouse.
Thyoglycollate
-treated
mice
will
yield
10.000.000
macrophages permouse.
But
treated
mice
with
Freund's
adjuvantsincomplete
only
have
2
X
10.000
macrophages permouse
after
5
days. Inflammatory agents
recruit
young, immature
macrophagesinto
peritoneum. Total
cell
yields
and
subpopulations
of
cells
will
differ
depending
on the
iritant
used.
Easily
digestible
in-flammatory
agentwill
induce
ashort-lived
inflamma-tory
response andthe animal
will
beable
to
return
tohomeostasis
within
days. On the other hand,
agentthat are more
difficult
to
digest, such as thyoglycollateor
colloidal
starch,
can
induce
an
inf-lammatorvresponse
in
vivo
that lastsfbr
5 to 7 days.r3Freund's
Adjuvants
is
water-in-oil
emulsion used
tostimulate immune
responses.There
aretwo forms of
Freund's adjuvants, depending
on
the
presence
or absenceof
killed
Mycobacteria. Complete
Freund'sAdjuvants contains Mycobacterium
tuberculosis,
orother
strains
of
Mycobacteria.
It
induces stroig
Granuloma
formation
at
the
site
of
injection
andenhances
the immune
response.Weak
antigens
may be renderedmore immunogenic when incorporated in
complete Freund's adj uvant.T' 8
Influence
of
inhibitor
protein
kinase
CStaurosporine
is
the
most
potent inhibitor
of
protein
kinase
C (PKC)
describedin
theliterature
with
ahalf
maximal
inhibitory
concentration
of
10
nM.
Never-theless,this
natural
product is poorly
selective
whenassayed
against other protein kinases.
In
order
toobtain specific PKC inhibitor, a
seriesof
bisindolyl-maleimides has
been synthezised.GF
109203X
was acompetitive
inhibitor
with
respecr
to
ATP
anddisplayed
high
selectivity
for
PKC as
compared
tofive
different protein
kinases.
In
further
experimentdetermined
the potency
and
specificity
of
GF
I09203X in two cellular
model :
humanplatelets and
Swiss
T3T
fibroblast.
GF
109203X
-
bisindolyl-maleimides inhibited collagen -
and alpha -thrombin
-induced platelet
aggregation
as
well
as collagen
-triggered
ATP
secretion.
In
Swiss 3T3 fibroblast, GF
109203X
reversedthe
inhibition
of
epidermal growth
factor binding induced
by
phorbol
12,l3-diburyrate
and prevented thymidine incorporation
into
DNA,
Med J htdones
only
when
this
was elicited
by
growth
promoting
agent
which
activate
PKC.
His
results illustrate
thepotential
of
GF
109203X
bisindolylmaleimides
as
atool
for
studying the-involvement
of
PKC
in
signal transduction pathway.3The protein
kinase
inhibitor
staurosporine has
been used to design a seriesof
selectivebisindolylmaleimide
inhibitors
of
protein kinase
C (PKC).
Guided
by
molecular graphics,
conformational restriction
of
thecationic side chain has
led
to
ATP
competitive
inhibitors
of
improved potency and selectivity.
Twcrcompounds
have been further evaluated and
were shownto
inhibit PKC of
humanorigin
and prevenrT-cell
activation
rn a
human
allogeneic
mixed
lyrnphocyte reaction. One
of
this
compounds
wasorally
absorbed
in
mice and
antagonized
a
phorbol
ester inducedpaw edema
in
a dose-dependent manner.This
compound also
selectively
inhibited
the secondaryT
cell
mediated
responsein
a
developing
adjuvant arthrrtis model
in
rats
andplovides
evidencefor
the potential
us
of PKC inhibitors
as therapeuticimmunomodulators
All
of
the PKCs have an amino-therminal regulatory
domain containing PS-binding
and
phorbol
esterbinding site.
This
domain
is
separated
fiom
thecarboxyl-terminal
catalytic
domain containing
theATP-binding
and_substrates-brnding
site
by
flexible
hinge
region.'-t'''
Inhibitors
of
PKC
coulcl
interact
with
the substrate-binding site
or with
regr-rlatory siteof PKC.
The structural
simrlarity
between
bisindolyl-maleimides
and
staurosporine suggested
thatbisindolylmaleimides
may be a competitive inhibitor
with
respect
to
ATP. The
inhibition
of
PKC
by
bisindolylmaleimides was demonstrated
ro be highly
dependent
on
theATP
concentration.
Dixon plot
ciataindicated
thatbisrndolylmaleimides
was a competiriveinhibitor
versus
ATP.
In
this
experiment
bisindolyl-maleimides
is
very
significant
in
inhibiting
themobility and activity
of
the
macrophages
in
phago-cytosis toward
Candida
sp
(seeFig. 3,
4,
7
and 8).
The
higher the bisindolylmaleimides
concenrrarion,the
sooner
the
time
observed,
the more PKCs
aregoing
inactive,
the
shorter the
length
of
pseudopodiathe lower the mobility and activity
of
phagocytosistoward Candida sp by
macrophages.Acknowledgments
We
thank the
Research
and Development
Vol 10, No 3, July
-
September 2001Biology
Institution-Eijkman-Jakarta,
Faculty
of
Medicine-University
of
Gadjah Mada, Faculty of
Veterinary-University
of
Gadjah
Mada and
specialthanks
to Prof.
Dr.
Noerhayati
Soeripto,DTM&H
andDrh. Widya Asmara,
SU, PhD"REFERENCES
L
Karp G. Cell
and
molecularBiology.
Concepts andexperiments",
John
Wiley
&
Sons.Inc. New
York-Sin-eapore. 1996, pp. 649-93.
2.
JakenS.
Protein kinaseC
isoenzymes and substrates.Current Biology Ltd. 1996, Vol. 8 : 168-'73.
3.
Bit RA, Davis PD, Elliot LH, Haris W,Hill
CH, Keech E,Kumar
H,
LawtonG,
Maw
A,
Nixon
JS, Vesey DR,Wadsworih J and Wilkinson SE. Inhibitor protein kinase
C. 3. potent and highly selective bisindolylmaleimides by
conformational restriction.
J
Med Chem. 199;336,2\-9.4.
ToullecD,
PianettiP,
CosteH,
Belleverque P,Grand-Perret
T,
AjakeneM,
BaudetV,
Boissin P, Boursier E,Lariolle F, Duhamel
L,
CharonT.
and Kirilovski J. TheBisindolylmaleimrde
GF
i09203X
is A
potent
andselective
inhibitor
of
protein kinaseC.
The AmericanSociety
lor
Biochemistry and Molecular Biology Inc.,usA.1991,
15771.5.
RoittI,
Brostoff J and MaleD,
1993. Immunology. 3rd. ed., Mosby. St Louis-Toronto. 1989, 15.9.6.
Stites DP and TerrAI Basic human immunology. First
ed., Prentice-Hall Intemational Inc., USA. 1991, pp.34-44.
Influence ofprotein kinase C inhibitor 157
Male
D.
Immunology and illustrated outline. 2nd ed.,Ivlosby. London. 1994, pp. 49-52 and 89 -98.
Rosen FS, Steiner [,A, Unanue ER. Macmillan Dictionary
of
hnmunology, Macmillan Reference Books. Londonand Basingstoke, pp. 107-22.
Strickland. Hunter's
tropical
medicine.7th
ed.,
WBSaunders Company. Philadelphia-Tokyo. 1991, pp. 507-8. William JW, Ernest B, Allan JE, Wayne RR. Hematology.
2nd ed.
Mc
Grow
Hill
Book
Company,A
Blakistone Publication, New York-St. [,ouis-San-Franscisco-Auck]and-Sydney-Tokyo-Toronto. 1977 . pp.85 1 -60.
JaweztEJL, Melnick, Alderberg EA. Review of Medical
Microbiology.
7th
ed.,
Appleton&
Lange.Norwalk-ConnecticuVlos Altos-California. I 987, pp. 621 -9.
Machmoud
AAF.
Tropical and geographical medicine.Znd
ed.Mc
Grow
Hill
InternationalEdition,
HealthProfessional Series, 1993. pp. 342-5.
Coligan JE, Kruisbeek AM, Marquilies DA, Shevach EM,
Strober
W,
CoicoR.
Current protocolsin
immunology.John Wiley
&
Sons. Inc. USA. 1994, Unit 11 and 14.Machrnoud AAF. Mononuclear phagosytes and resistance.
"Immunology
and
molecular
biology
of
parasiticinfection", Kenneth SW (ed)
MD,
BlackWeli
ScientificPublication, Boston. 1993, pp. 23-4.
Swanson JA. Phorbol Ester Stimulate Macropinocytosis
and solute
flow
through macrophages.J
Cell
Science.1989, 94:135-42.
'ljokronegoro
A,
UtomoB,
RukmonoB.
Dasar-dasar Metodologi RisetIlmu
Kedokteran, DepartemenPen-didikan dan Kebudayaan, Konsorsium
Ilmu
Kedokteran,Jakarta,1981. 1
8.
9.
11.
i0
l2
13
t4
15